Medtronic plc (MDT)
Medtronic (MDT) Stock Sinks As Market Gains: Here's Why
In the latest trading session, Medtronic (MDT) closed at $77.79, marking a -2.76% move from the previous day.
Medtronic (MDT) Declines More Than Market: Some Information for Investors
Medtronic (MDT) closed the most recent trading day at $78.3, moving 2.13% from the previous trading session.
Medtronic: Expectations Are Low And That's The Opportunity
Medtronic is a diversified MedTech company undergoing business simplification and cost improvements, with a focus on margin recovery over high growth. MDT trades at a discount to peers, reflecting lower growth expectations, but current levels offer a reasonable entry into a stable, cash-generative business. Margin improvement, especially through the diabetes business separation and streamlined operations, is the key catalyst for potential re-rating and upside.
Advisors Capital Management LLC Has $43.69 Million Stake in Medtronic PLC $MDT
Advisors Capital Management LLC grew its holdings in Medtronic PLC (NYSE: MDT) by 4.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 454,855 shares of the medical technology company's stock after purchasing an additional 19,479 shares during the period. Advisors Capital
Medtronic: Is This Dividend Aristocrat Finally A "Buy" Before Earnings?
Medtronic plc remains a medical device stalwart with a robust product portfolio, but faces slow growth, high debt, and competitive pressures. I maintain a Hold rating due to a 2.76 PEG ratio, modest revenue growth, and capital deployment concerns; a further 20% price drop would improve attractiveness. Cardiac Ablation Solutions and Stealth AXIS robotic system are current growth drivers, while HUGO faces entrenched competition and limited market share potential.
Caprock Group LLC Acquires 11,167 Shares of Medtronic PLC $MDT
Caprock Group LLC grew its holdings in shares of Medtronic PLC (NYSE: MDT) by 16.0% in the undefined quarter, according to its most recent disclosure with the SEC. The fund owned 80,968 shares of the medical technology company's stock after acquiring an additional 11,167 shares during the period. Caprock Group LLC's holdings in
Medtronic (MDT) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Medtronic (MDT) closed the most recent trading day at $82, moving 3.53% from the previous trading session.
Is Medtronic (MDT) a Buy as Wall Street Analysts Look Optimistic?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Medtronic (MDT) Stock Drops Despite Market Gains: Important Facts to Note
Medtronic (MDT) reached $87.1 at the closing of the latest trading day, reflecting a -1.16% change compared to its last close.
Medtronic (MDT) Beats Stock Market Upswing: What Investors Need to Know
In the latest trading session, Medtronic (MDT) closed at $88.65, marking a +2.58% move from the previous day.
Medtronic (MDT) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Medtronic (MDT) concluded the recent trading session at $85.74, signifying a -1.61% move from its prior day's close.
MDT Expands Agreement With Merit to Offer ViaVerte: Stock to Gain?
Medtronic expands its pain portfolio with a new ViaVerte BVNA system deal with Merit, aiming to tap rising demand for minimally invasive chronic pain treatments.
